137 related articles for article (PubMed ID: 38671289)
1. ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective Observational Study.
Ślusarczyk A; Ismail H; Zapała Ł; Piecha T; Zapała P; Radziszewski P
Ann Surg Oncol; 2024 Jul; 31(7):4811. PubMed ID: 38671289
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
Ślusarczyk A
Ann Surg Oncol; 2024 Jun; 31(6):3910-3911. PubMed ID: 38602577
[No Abstract] [Full Text] [Related]
3. Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
Ślusarczyk A; Ismail H; Zapała Ł; Piecha T; Zapała P; Radziszewski P
Ann Surg Oncol; 2024 Jul; 31(7):4773-4786. PubMed ID: 38570378
[TBL] [Abstract][Full Text] [Related]
4. Quality of transurethral resection of bladder tumour documentation: implications for non-muscle-invasive bladder cancer risk stratification and management.
Botros A; Rival PM; Page F; Davis ID; Sengupta S
BJU Int; 2024 Apr; 133 Suppl 4():7-10. PubMed ID: 38116588
[No Abstract] [Full Text] [Related]
5. Editorial Comment to Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
Fukushima H
Int J Urol; 2023 Dec; 30(12):1120-1121. PubMed ID: 37740488
[No Abstract] [Full Text] [Related]
6. Editorial Comment from Dr Tellini et al. to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Tellini R; Mari A; Minervini A
Int J Urol; 2022 Jul; 29(7):640. PubMed ID: 35384083
[No Abstract] [Full Text] [Related]
7. Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Hayakawa N; Kikuchi E
Int J Urol; 2022 Jul; 29(7):639-640. PubMed ID: 35368133
[No Abstract] [Full Text] [Related]
8. Editorial Comment from Dr Naselli and Dr Pirola to Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Naselli A; Pirola GM
Int J Urol; 2022 Jul; 29(7):638-639. PubMed ID: 35362114
[No Abstract] [Full Text] [Related]
9. Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.
Audenet F; Waingankar N; Ferket BS; Niglio SA; Marqueen KE; Sfakianos JP; Galsky MD
J Urol; 2018 Nov; 200(5):996-1004. PubMed ID: 29879397
[TBL] [Abstract][Full Text] [Related]
10. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
13. Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Kobayashi K; Matsuyama H; Kawai T; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Komura K; Abe T; Kume H; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Inoue K; Mitsui T; Kawakita M; Ohyama C; Mizokami A; Kuroiwa H
Int J Urol; 2022 Jul; 29(7):632-638. PubMed ID: 35293022
[TBL] [Abstract][Full Text] [Related]
14. Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer.
Gore JL; Wolff EM; Comstock BA; Follmer KM; Nash MG; Basu A; Chisolm S; MacLean DB; Lee JR; Lotan Y; Porten SP; Steinberg GD; Chang SS; Gilbert SM; Kessler LG; Smith AB;
BMC Cancer; 2023 Nov; 23(1):1127. PubMed ID: 37980511
[TBL] [Abstract][Full Text] [Related]
15. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer.
Xu S; Yao Q; Liu G; Jin D; Chen H; Xu J; Li Z; Wu G
Eur Radiol; 2020 Mar; 30(3):1804-1812. PubMed ID: 31773297
[TBL] [Abstract][Full Text] [Related]
16. Bladder sparing surgery in high-grade bladder cancer.
Yakovlev PG; Klyushin DA; Vereshchako RI
Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
[TBL] [Abstract][Full Text] [Related]
17. Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.
Bree KK; Kokorovic A; Westerman ME; Hensley PJ; Brooks NA; Qiao W; Shen Y; Kamat AM; Dinney CP; Navai N
J Urol; 2023 Jan; 209(1):140-149. PubMed ID: 36250944
[TBL] [Abstract][Full Text] [Related]
18. Restaging transurethral resection for non-muscle invasive bladder cancer: who, why, when, and how?
Ritch CR; Clark PE; Morgan TM
Urol Clin North Am; 2013 May; 40(2):295-304. PubMed ID: 23540786
[TBL] [Abstract][Full Text] [Related]
19. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
20. Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply.
Bree KK; Navai N
J Urol; 2023 Dec; 210(6):839. PubMed ID: 37747096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
